NCT00129337 Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies Status COMPLETED Phase PHASE1
NCT00129207 Ketoconazole Administration: How it is Affected by the Body and Broken Down and How it Acts on the Body When Used With Velcade Status COMPLETED Phase PHASE1
NCT00127829 Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or Metastatic Status COMPLETED Phase PHASE1
NCT00127127 A Study of Vorinostat in Patients With Solid Tumors (MK-0683-029) Status COMPLETED Phase PHASE1
NCT00125411 Study of Satraplatin (JM-216) in Combination With Docetaxel Status TERMINATED Phase PHASE1
NCT00113113 Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction Status COMPLETED Phase PHASE1
NCT00105170 Safety and Tolerability of hCBE-11 in Subjects With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT00102830 Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00093873 Study Evaluating AMG 706 in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00091806 Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00060645 Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00060632 Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00024492 Study of Liposome Encapsulated Mitoxantrone (LEM) in Patients With Advanced Cancer Status COMPLETED Phase PHASE1